A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo - PubMed (original) (raw)

. 2006 Nov;13(11):1217-26.

doi: 10.1016/j.chembiol.2006.09.013.

Bogdan I Florea, Victoria Menendez-Benito, Christa J Maynard, Martin D Witte, Wouter A van der Linden, Adrianus M C H van den Nieuwendijk, Tanja Hofmann, Celia R Berkers, Fijs W B van Leeuwen, Tom A Groothuis, Michiel A Leeuwenburgh, Huib Ovaa, Jacques J Neefjes, Dmitri V Filippov, Gijs A van der Marel, Nico P Dantuma, Herman S Overkleeft

Affiliations

A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo

Martijn Verdoes et al. Chem Biol. 2006 Nov.

Abstract

The proteasome is an essential evolutionary conserved protease involved in many regulatory systems. Here, we describe the synthesis and characterization of the activity-based, fluorescent, and cell-permeable inhibitor Bodipy TMR-Ahx(3)L(3)VS (MV151), which specifically targets all active subunits of the proteasome and immunoproteasome in living cells, allowing for rapid and sensitive in-gel detection. The inhibition profile of a panel of commonly used proteasome inhibitors could be readily determined by MV151 labeling. Administration of MV151 to mice allowed for in vivo labeling of proteasomes, which correlated with inhibition of proteasomal degradation in the affected tissues. This probe can be used for many applications ranging from clinical profiling of proteasome activity, to biochemical analysis of subunit specificity of inhibitors, and to cell biological analysis of the proteasome function and dynamics in living cells.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources